X4 Pharmaceuticals, Inc.XFORNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-10.54%
↓ 122% below average
Average (36q)
47.59%
Historical baseline
Range
High:1908.86%
Low:-100.00%
Volatility
4221.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -10.54% |
| Q2 2025 | -93.15% |
| Q1 2025 | 1908.86% |
| Q4 2024 | 156.07% |
| Q3 2024 | -0.53% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | -100.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |